Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins

Virus Research

Volumn 123, Issue 1, 2007, Pages 40-49

  Kouvatsis, V ^a   Argnani, R ^b   Tsitoura, E ^a   Arsenakis, M ^c   Georgopoulou, U ^a   Mavromara, P ^a   Manservigi, R ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF FERRARA   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

gC:E2 chimeric proteins; HCD81; HCV; Heparan sulphate; HSV 1

Indexed keywords

CHIMERIC PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN E2; GLYCOPROTEIN GC; HEPARAN SULFATE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CERCOPITHECIDAE; CONTROLLED STUDY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; VIRION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, CD; CELL LINE; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; HUMANS; PROTEIN STRUCTURE, TERTIARY; REASSORTANT VIRUSES; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

CUCURBITA PEPO VAR. MELOPEPO; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1;

EID: 33750988223     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.07.017     Document Type: Article

References (58)

1. Anderson D.B., Laquerre S., Ghosh K., Ghosh H.P., Goins W.F., Cohen J.B., and Glorioso J.C. Pseudotyping of glycoprotein d-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J. Virol. 74 (2000) 2481-2487
2. Argnani R., Boccafogli L., Marconi P.C., and Manservigi R. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. Gene Ther. 11 (2004) 1087-1098
3. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., and Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 (2003) 41003-41012
4. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197 (2003) 633-642
5. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 (2003) 41624-41630
6. Basu A., Beyene A., Meyer K., and Ray R. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J. Virol. 78 (2004) 4478-4486
7. Baumert T.F., Ito S., Wong D.T., and Liang T.J. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J. Virol. 72 (1998) 3827-3836
8. Buonocore L., Blight K.J., Rice C.M., and Rose J.K. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J. Virol. 76 (2002) 6865-6872
9. Cai Z., Zhang C., Chang K.S., Jiang J., Ahn B.C., Wakita T., Liang T.J., and Luo G. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79 (2005) 13963-13973
10. Chan-Fook C., Jiang W.R., Clarke B.E., Zitzmann N., Maidens C., McKeating J.A., and Jones I.M. Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity. Virology 20 273 (2000) 60-66
11. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., and Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3 (1997) 866-871
12. Cormier E.G., Tsamis F., Kajumo F., Durso R.J., Gardner J.P., and Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 7270-7274
13. Drummer H.E., Wilson K.A., and Poumbourios P. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J. Virol. 76 (2002) 11143-11147
14. Flint M., Logvinoff C., Rice C.M., and McKeating J.A. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J. Virol. 78 (2004) 6875-6882
15. Frink R.J., Eisenberg R., Cohen G., and Wagner E.K. Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J. Virol. 45 (1983) 634-647
16. Germi R., Crance J.M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R.W., Zarski J.P., and Drouet E. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292 (2002) 162-168
17. Goffard A., Callens N., Bartosch B., Wychowski C., Cosset F.L., Montpellier C., and Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79 (2005) 8400-8409
18. Goffard A., and Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 85 (2003) 295-301
19. Grandi P., Wang S., Schuback D., Krasnykh V., Spear M., Curiel D.T., Manservigi R., and Breakefield X.O. HSV-1 virions engineered for specific binding to cell surface receptors. Mol. Ther. 9 (2004) 419-427
20. Higginbottom A., Quinn E.R., Kuo C.C., Flint M., Wilson L.H., Bianchi E., Nicosia A., Monk P.N., McKeating J.A., and Levy S. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J. Virol. 74 (2000) 3642-3649
21. Hilgard P., and Stockert R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 32 (2000) 1069-1077
22. Hulst M.M., van Gennip H.G., Vlot A.C., Schooten E., de Smit A.J., and Moormann R.J. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence. J. Virol. 75 (2001) 9585-9595
23. Lagging L.M., Meyer K., Owens R.J., and Ray R. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J. Virol. 72 (1998) 3539-3546
24. Lambot M., Fretier S., Op D.B., Quatannens B., Lestavel S., Clavey V., and Dubuisson J. Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J. Biol. Chem. 277 (2002) 20625-20630
25. Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., and Glorioso J.C. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72 (1998) 6119-6130
26. Lauterbach H., Kerksiek K.M., Busch D.H., Berto E., Bozac A., Mavromara P., Manservigi R., Epstein A.L., Marconi P., and Brocker T. Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1. J. Virol. 78 (2004) 4020-4028
27. Lauterbach H., Ried C., Epstein A.L., Marconi P., and Brocker T. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J. Gen. Virol. 86 (2005) 2401-2410
28. Lavillette D., Tarr A.W., Voisset C., Donot P., Bartosch B., Bain C., Patel A.H., Dubuisson J., Ball J.K., and Cosset F.L. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41 (2005) 265-274
29. Levy S., Todd S.C., and Maecker H.T. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16 89-109 (1998) 89-109
30. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
31. Major, M.E., Rehermann, B., Feinstone, S.M., 2001. Fields Virology, first ed., pp. 1127-1162.
32. Mandl C.W., Kroschewski H., Allison S.L., Kofler R., Holzmann H., Meixner T., and Heinz F.X. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 75 (2001) 5627-5637
33. Mardberg K., Trybala E., Glorioso J.C., and Bergstrom T. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J. Gen. Virol. 82 (2001) 1941-1950
34. Matsuura Y., Tani H., Suzuki K., Kimura-Someya T., Suzuki R., Aizaki H., Ishii K., Moriishi K., Robison C.S., Whitt M.A., and Miyamura T. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286 (2001) 263-275
35. Meyer K., Basu A., and Ray R. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. Virology 276 (2000) 214-226
36. Meyer K., Beyene A., Bowlin T.L., Basu A., and Ray R. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer. J. Virol. 78 (2004) 12838-12847
37. Op D.B., Cocquerel L., and Dubuisson J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82 (2001) 2589-2595
38. Op D.B., and Dubuisson J. Topology of hepatitis C virus envelope glycoproteins. Rev. Med. Virol. 13 (2003) 233-241
39. Penin F., Combet C., Germanidis G., Frainais P.O., Deleage G., and Pawlotsky J.M. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J. Virol. 75 (2001) 5703-5710
40. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
41. Roccasecca R., Ansuini H., Vitelli A., Meola A., Scarselli E., Acali S., Pezzanera M., Ercole B.B., McKeating J., Yagnik A., Lahm A., Tramontano A., Cortese R., and Nicosia A. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J. Virol. 77 (2003) 1856-1867
42. Roizman B., and Whitley R.J. The nine ages of herpes simplex virus. Herpes 8 (2001) 23-27
43. Shieh M.T., WuDunn D., Montgomery R.I., Esko J.D., and Spear P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116 (1992) 1273-1281
44. Shukla D., and Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108 (2001) 503-510
45. Spear P.G., and Longnecker R. Herpesvirus entry: an update. J. Virol. 77 (2003) 10179-10185
46. Takikawa S., Ishii K., Aizaki H., Suzuki T., Asakura H., Matsuura Y., and Miyamura T. Cell fusion activity of hepatitis C virus envelope proteins. J. Virol. 74 (2000) 5066-5074
47. Triyatni M., Vergalla J., Davis A.R., Hadlock K.G., Foung S.K., and Liang T.J. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 20 298 (2002) 124-132
48. Trybala E., Bergstrom T., Svennerholm B., Jeansson S., Glorioso J.C., and Olofsson S. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J. Gen. Virol. 75 (1994) 743-752
49. Tsitoura E., Lucas M., Revol-Guyot V., Epstein A.L., Manservigi R., and Mavromara P. Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. J. Gen. Virol. 83 (2002) 561-566
50. Varaklioti A., Vassilaki N., Georgopoulou U., and Mavromara P. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J. Biol. Chem. 277 (2002) 17713-17721
51. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
52. Walewski J.L., Keller T.R., Stump D.D., and Branch A.D. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7 (2001) 710-721
53. Welnitz S., Klumpp B., Barth H., Ito S., Depla E., Dubuisson J., Blum H.E., and Baumert T.F. Binding of hepatis C virus-like particles derived from infectious clone H77C to defined human cell lines. J. Virol. 76 (2002) 1181-1193
54. Whitley R.J., and Roizman B. Herpes simplex virus infections. Lancet 357 (2001) 1513-1518
55. Xu Z., Choi J., Yen T.S., Lu W., Strohecker A., Govindarajan S., Chien D., Selby M.J., and Ou J. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20 (2001) 3840-3848
56. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 (2004) 1448-1455
57. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9294-9299
58. Zhou G., and Roizman B. Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells. J. Virol. 79 (2005) 5272-5277